CLS Investments »

SPDR S&P Pharmaceuticals shares owned by CLS Investments

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by CLS Investments

Quarter filed Position value Share count Share price at filing
2013-03-31 $4.5M 72k 63.16
2012-12-31 $6.3M 112k 55.91
2012-09-30 $5.5M 92k 59.77
2012-03-31 $7.0M 122k 57.10
2011-12-31 $6.3M 122k 51.33
2011-06-30 $5.9M 116k 50.91

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Value Etf (VTV)

View all positions for CLS Investments

Top funds holding SPDR S&P Pharmaceuticals

Envestnet Asset Management
LPL Financial
Wells Fargo & Company
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Susquehanna International
Bnp Paribas Arbitrage, Snc
Cetera Investment Advisers
Jpmorgan Chase & Co
UBS Group
Clark Capital Management Group
Wharton Business Group
Bp Wealth Management
Mml Investors Services
Goldman Sachs Group

View all funds holding SPDR S&P Pharmaceuticals